Ashwin Sonkamble null, Somiya Gautam 1 null, Ashwin Sonkamble 2 null, Poornima Sonkamble 3 null, Usha Badole 4 null
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.
Somiya Gautam, Ashwin Sonkamble, Poornima Sonkamble, et al./Comparative Evaluation of Effect, Onset & Duration of Intranasal Dexmedetomidine Vs Midazolam for Paediatrics Sedation During Diagnostic CT Scan/ Indian J Anesth Analg. 2022;9(3)119-123
Background: Separation anxiety among children is common and normal.Children undergoing radiological imaging studies often require sedation to avoid panic episodes & severe anxiety for induction of Anaesthesia. It is important for the child to lie still during the scanning procedure & mostly we find it difficult for the children to keep still during a CT scan, which is usually about 10–15 minutes. This study aimed at comparing and evaluating the efficacy of use of intranasally administered Dexmedetomidine Vs intranasal midazolam for paediatric sedation undergoing diagnostic CT scan studies.
Methods: 100 paediatric patients within age group 1-10 years were divided into 2 groups of 50 patients each, Group I & II respectively, were given either intranasal Dexmedetomidine or Intranasal Midazolam. The depth of sedation was assessed by using University of Michigan sedation scale.
Results: This study concluded that Intranasal Dexmedetomidine is superior & more effective than Midazolam for pediatric sedation.
Somiya Gautam, Ashwin Sonkamble, Poornima Sonkamble, et al./Comparative Evaluation of Effect, Onset & Duration of Intranasal Dexmedetomidine Vs Midazolam for Paediatrics Sedation During Diagnostic CT Scan/ Indian J Anesth Analg. 2022;9(3)119-123
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.
| Received | Accepted | Published |
|---|---|---|
| April 25, 2022 | May 26, 2022 | June 20, 2022 |
Monday 13 July 2026, 12:32:15 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | April 25, 2022 |
| Accepted | May 26, 2022 |
| Published | June 20, 2022 |
This license enables reusers to
distribute, remix, adapt, and build upon the material in any medium or format
for noncommercial purposes only, and only so long as attribution is given to
the creator.